Search

Novo Nordisk Suffers Blow in Brazil as Court Rejects Bid to Block 'Local Ozempic'

A Brazilian federal court has denied Novo Nordisk's request to block local pharmaceutical giant EMS from using the trademark 'Ozivy' for its generic semaglutide, opening the door to fierce low-cost competition.